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barrier and antimicrobial defense  [1–4] . Aging is a ma-
jor endogenous factor that leads to increased skin pH 
 [5, 6] . A direct correlation between aging and the pH 
measured on skin surface (pH SS ) has been described 
 [2, 7–9] . The altered pH SS is supposed to be linked to 
clinical symptoms like rough and dry skin, which is 
sometimes associated with itching, as well as increased 
skin infections and susceptibility to contact allergies 
 [10, 11] .
 A further endogenous factor with increasing preva-
lence is diabetes mellitus. Yosipovitch et al.  [12] have 
shown that pH SS in intertriginous regions of diabetic pa-
tients is significantly increased compared to nondiabet-
ic subjects. Therefore, skin care products should be de-
signed in order to preserve or restore the physiologi-
cally protective acid mantle  [6, 11] . Skin care products 
for the elderly or diabetics should be developed as water-
in-oil (W/O) formulations because of prolonged skin-
hydrating effects  [13] . The development of stable W/O 
lotions and creams is more challenging compared to oil-
in-water (O/W) formulations, especially if the pH of the 
water phase has to be acidic. Therefore, excipients must 
be chosen carefully to guarantee stability of the formula-
tion because emulsifiers often hydrolyze under acidic 
conditions, leading to a loss of function and a disagree-
able smell.
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 Abstract 
 The skin pH is crucial for physiological skin functions. A de-
cline in stratum corneum acidity, as observed in aged or dis-
eased skin, may negatively affect physiological skin func-
tions. Therefore, glycolic acid-containing water-in-oil (W/O) 
emulsions adjusted to pH 4 were investigated regarding 
their effect on normal or increased skin pH. A pH 4 W/O emul-
sion was applied on three areas with pathologically in-
creased skin surface pH in diabetics (n = 10). Further, a 28-
day half-side trial (n = 30) was performed to test the long-
term efficacy and safety of a pH 4 W/O emulsion (n = 30). In 
summary, the application of a pH 4 W/O emulsion reduced 
the skin pH in healthy, elderly and diabetic subjects, which 
may improve epidermal barrier functions. 
 © 2015 The Author(s)
Published by S. Karger AG, Basel 
 Introduction 
 A proper regulation of skin pH is crucial for physi-
ological skin functions such as integrity/cohesion of the 
stratum corneum (SC), homeostasis of the epidermal 
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 Topical α-hydroxy acid (e.g. glycolic acid)-containing 
O/W formulations are widely used in cosmetics and der-
matology  [14] . In a previous study, we showed that the 
application of a 10% glycolic acid-containing O/W emul-
sion with pH 4 reduced not only the pH SS but also led to 
a significant decrease of the pH in deeper layers of the SC 
(pH SC ), very likely even affecting the stratum granulosum 
 [15] . 
 To prove that similar effects can be achieved with 
glycolic acid-containing W/O emulsion with pH 4, 
three independent clinical studies were performed to 
investigate efficacy and tolerability – a study on pH SS 
and pH SC in healthy subjects, a study on pH SS in diabet-
ics and a 4-week study assessing efficacy (pH SS ) and tol-
erability in elderly subjects.
 Methods 
 pH and Skin Hydration Measurement 
 pH SS and pH SC were recorded using a standard hydrogen glass 
electrode (SI Analytics GmbH, Mainz, Germany). Values were re-
corded 1 min after application of the electrode. Skin hydration was 
measured with a Corneometer MPA 5 CPU.
 Cosmeceutical Formulation 
 For the study in diabetic subjects, we used a W/O emulsion 
containing water, cetearyl isononanoate, dicaprylyl ether, cera 
alba, hexyl laurate, caprylic/capric triglyceride, glycerin, PEG-7 
hydrogenated castor oil, cetyl alcohol, zinc stearate, ceresin, gly-
colic acid, phenoxyethanol, magnesium sulfate, PEG-30 dipolyhy-
droxystearate, ethyl linoleate, glyceryl caprylate, ethyl oleate, ethyl 
palmitate, tocopherol, ethyl stearate,  Helianthus annuus seed oil, 
and allantoin. In all other studies, we used a W/O emulsion con-
sisting of water, sorbitan oleate, polyglyceryl-3-polyricinoleate, 
isohexadecane, ethylhexyl stearate, decyl oleate, sucrose polystea-
rate, tocopherol, ammonium hydroxide, glycerol, magnesium sul-
fate, and fragrance: limonene, linalool and citral. Glycolic acid was 
added to the water phase of the formulations to achieve a pH of 
about 4.
 Study Subjects 
 The volunteers had not exercised, washed or applied topical 
formulations to the measured areas for at least 24 h prior to the 
measurements. All participants were provided with verbal as well 
as written information on the study and informed consent was 
obtained from each subject. All experiments were conducted in 
accordance with the current version of the Declaration of 
 Helsinki.
 Clinical Trial in Healthy Subjects to Assess pH SS and pH SC 
 None of the volunteers (n = 6, 29.9 ± 4.7 years) had a history 
of skin disorders nor did they suffer from a skin condition at the 
time of measurement. A pH 4 W/O emulsion (2 mg/cm 2 ) was 
applied homogenously on the volar forearm. Tape stripping was 
performed 10 min after application and pH SC was measured after 
every 10 tape strippings. In total, 100 tape strippings were per-
formed to remove the complete SC  [16, 17] . Changes in pH SS 
over time were measured without removal of the SC on the oth-
er arm.
 Clinical Trial in Diabetics to Assess pH SS 
 Male volunteers (diabetics: n = 10, 70.2 ± 2.6 years; nondiabet-
ics: n = 10, 59.8 ± 3.5 years) were included for measurement of 
pH SS of the axillary, inguinal, interdigital and plantar region, as 
well as of the lower leg and the dorsum of the foot. In addition, 
diabetic volunteers applied a pH 4 W/O emulsion to one foot of 
each patient (randomized) twice daily for 2 weeks and pH SS was 
measured thereafter. The respective untreated foot of the other 
side served as control. All diabetic volunteers suffered from insu-
lin-dependent diabetes mellitus. Diabetes was diagnosed 12.3 ± 
2.9 years prior to measurements. HbA 1c of diabetics amounted to 
7.8 ± 0.4% and blood sugar levels were 164 ± 18.1 and 131.4 ± 
12.7 mg/dl, respectively (data not shown). Bacterial colonization 
was assessed by swabs before and after application of the emulsion. 
However, due to the limited sample size, there was only a trend 
towards bacterial reduction following application of the emulsion 
(data not shown).
 Clinical Trial to Assess Long-Term Efficacy and Tolerability 
 A 28-day trial was performed (n = 30, 70.2 ± 5.2 years). The 
pH 4 W/O emulsion was applied 2–4 times daily by choice of vol-
unteers on the volar forearm. The respective untreated volar fore-
arm of the other arm served as control. Skin hydration and pH SS 
were measured at baseline, after 14 days of application and finally 
at day 28. A subjective evaluation of the treatment was done by 
questionnaire.
 Statistics 
 All data are presented as mean ± standard error of the mean 
(SEM). For statistical analyses, H + concentrations were calculat-
ed from the respective pH values. In terms of baseline pH SS , dif-
ferences between localizations were analyzed with one-way Krus-
kal-Wallis ANOVA on rank and post hoc Tukey tests. For com-
parisons of pH before and after treatment, paired t tests (in case 
normality testing passed) and Wilcoxon signed-rank tests (in 
case normality testing failed) were done. Long-term study was 
evaluated by descriptive statistics using the Wilcoxon signed-
rank test.
 Results 
 Clinical Trial in Healthy Subjects to Assess pH SS and 
pH SC 
 The overall impact of the pH 4 W/O emulsion was ini-
tially investigated on healthy subjects. Baseline pH SS was 
measured at 4.44 ± 0.18. Immediately after application of 
the pH 4 O/W emulsion, pH SS was 3.53 ± 0.13. pH SS then 
increased steadily over the next 2 h, finally reaching 4.38 ± 
0.32 ( fig. 1 a). The decline of pH SC after the application 
of pH 4 W/O emulsion could also be measured in deeper 
layers of the SC. After 10 tape strippings, a pH SC of 4.07 ± 
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0.22 was measured and with further strippings pH SC still 
remained markedly reduced ( fig. 1 b) compared to values 
we had previously measured on untreated skin  [18] .
 Clinical Trial in Diabetics to Assess pH SS 
 There were no significant differences in pH SS between 
diabetics and controls on the bottom and the dorsum of 
the foot, as well as in the interdigital region ( fig. 2 a, b). 
Additionally, no significant differences were detected be-
tween the left and right foot – both for diabetics and con-
trols. However, interdigital pH SS of the left foot was sig-
nificantly higher compared to pH SS on the dorsum 
( fig. 2 a). A similar tendency was seen on the right foot but 
the results were not significant ( fig. 2 b). For the other lo-
calizations (axillary and inguinal regions and the lower 
leg), there were no significant differences in pH SS between 
diabetics and controls ( fig. 2 c). In diabetic patients, how-
ever, we found significantly lower pH SS values on the low-
er leg compared to the axillary and inguinal regions. 
Even though not significant, pH SS was slightly higher at 
all localizations in diabetics than in control patients 
( fig.  2 a–c). Overall, intertriginous regions exhibited 
slightly higher pH SS values. Topical application of pH 
4 W/O emulsion for 2 weeks led to a significant reduction 
in pH SS on the bottom and the dorsum of the foot, as well 
as interdigitally ( fig. 3 ).
 Clinical Trial to Assess Long-Term Efficacy and 
Tolerability 
 Evaluation of long-term efficacy and tolerability was 
addressed over 28 days in elderly volunteers. Already af-
ter 14 days but also after 28 days of treatment, a statisti-
cally significant increase in skin hydration was observed 
at the treated volar forearm in all study participants com-
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 Fig. 1. The pH4 W/O emulsion (2 mg/cm 2 ) 
was applied homogenously on the volar 
forearm of healthy volunteers (n = 6, 29.9 ± 
4.7 years).  a pH SC was recorded using a 
standard hydrogen glass electrode.  b Tape 
stripping was performed 10 min after ap-
plication and pH SC was measured after ev-
ery 10 tape strippings. 
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 Fig. 2. Male volunteers (diabetics: n = 10, 70.2 ± 2.6 years; nondia-
betics: n = 10, 59.8 ± 3.5 years) were included for measurement of 
pH SS of plantar, dorsum and interdigital regions of the left foot ( a ), 
plantar, dorsum and interdigital regions of the right foot ( b ) and 
axillary and inguinal regions, as well as the lower leg ( c ). Mean ± 
SEM.  * p < 0.05, post hoc Tukey test. 
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pared to the untreated control site. Mean Corneometer 
readings increased by 9.5 units after 14 days and in-
creased further by 12.1 units after 28 days ( fig. 4 a). Ad-
ditionally, pH SS values were reduced by 0.38 after 14 days 
and even by 0.52 after 28 days of application compared 
to untreated areas on the respective other volar forearm 
( fig. 4 b).
 Discussion 
 In contrast to previous studies investigating a pH 
4 O/W emulsion  [15] , the effect on pH SS of a pH 4 W/O 
emulsion was investigated regarding the acidifying prop-
erties. The two different emulsion types (W/O and O/W) 
exhibit different properties and thus differ with respect to 
influencing the pH SS . In the case of a W/O emulsion the 
acidified inner water phase must be released, which high-
ly depends on the stability of the emulsion. A stable W/O 
emulsion would hypothetically slow down the release of 
H + and a delayed pH SS declining effect compared to O/W 
emulsion can be observed. However, as shown in this 
short-term study in healthy volunteers, rather immedi-
ately after topical application of the pH 4 W/O emulsion 
a significant decrease of pH SS could be measured. This 
rapid positive effect on pH SS emphasizes the appropriate 
galenical formulation of the pH 4 W/O emulsion. Since 
no data are available, it is hypothesized that the speed of 
pH regulation by W/O emulsions depends strongly on 
the release of the inner acidic water phase. This can only 
be achieved by an intended release due to the adjusted 
stability of the W/O emulsion by the use of appropriate 
emulsifiers [U. Knie, pers. commun.].
 Different factors (e.g. aging or diseases like diabetes 
mellitus) influence the pH SS and therefore impact the 
physiological functions of the skin negatively. The differ-
ence of pH SS in diabetics and control patients was not 
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 Fig. 3. In addition, diabetic volunteers applied a pH 4 W/O emul-
sion to one foot of each patient (randomized) twice daily for 2 
weeks and pH SS reduced significantly on the bottom of the foot 
(p = 0.002, Wilcoxon signed-rank test) and the dorsum of the foot 
(p = 0.002, Wilcoxon signed-rank test), as well as interdigitally (p = 
0.005, paired t test). The respective untreated foot of the other side 
served as control. 
 Fig. 4. A 28-day trial was performed (n = 30, 70.2 ± 5.2 years). 
A pH4 W/O emulsion was applied 2–4 times daily by choice of 
volunteers on the volar forearm. The respective untreated volar 
forearm of the other arm served as control.  a Skin hydration was 
measured after 14 days of application and finally at day 28 
(Δ-values calculated to baseline).  b pH SS was measured after 14 
days of application and finally at day 28 (Δ-values calculated to 
baseline). 
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significantly different in our study – maybe due to the 
limited number of subjects. In contrast, an increased 
pH SS in diabetics was observed at all localizations, ac-
cording to the literature  [12] . However, the treatment of 
diabetic patients with a pH 4 W/O emulsion led to a sig-
nificant reduction of pH SS on the bottom of the foot, the 
dorsum of the foot and in the interdigital area of the foot, 
restoring a physiological pH SS . A physiological pH SS may 
lead to improved epidermal barrier integrity, thus per-
haps reducing cutaneous manifestations, e.g. microbial 
infections, due to an impaired epidermal barrier in dia-
betic patients  [1, 4] . Furthermore, it is known that also 
during aging, pH SS increases at different localizations 
(forearm, temple and forehead)  [2] , which contributes to 
reduced epidermal integrity and impaired epidermal ho-
meostasis. Furthermore, these changes render the skin 
more susceptible to microbial colonization  [1, 3, 4, 19] .
 To the best of our knowledge, this is the first study us-
ing a pH 4-adjusted W/O emulsion to revert an increased 
skin pH in the elderly, as recommended by Maibach and 
Levin  [11] . Topical long-term application of the pH 4 
W/O emulsion resulted not only in increased skin hydra-
tion but also in a significant decrease of pH SS already after 
14 days. This effect continued until the end of the study 
(day 28) and a further decrease was observed. This find-
ing is not in contrast to an independent study by Burac-
zewska and Lodén  [20] , where they failed to prove the 
superiority of a cream of pH 4.0 over a cream of pH 7.5 
regarding the promotion of skin barrier recovery. How-
ever, application in this study was only for a short-term 
period of 7 days. Interestingly, comparable effects were 
observed with a pH 4 O/W emulsion after 14 days of ap-
plication  [21] . However, in this study no further decrease 
after 14 days was observed. This limited pH SS adjusting 
effect of the pH 4 O/W emulsion is probably due to the 
different galenical formulation of the emulsion and an 
only once daily application compared to the study pre-
sented here with an application of W/O emulsion 2–4 
times daily, which is very likely more effective. 
 In conclusion, the skin of elderly and diabetic subjects 
exhibiting a higher pH SS is very likely to benefit from skin 
care products with an acidic pH to normalize increased 
pH SS values. Regular application may improve skin func-
tions. Moreover, acidifying the skin surface to physiolog-
ical pH values reduces dry skin as well as skin sensitivity 
towards infection and irritation by improving cohesion 
of corneocytes and homeostasis of the epidermal barrier. 
The latter effect may depend upon acidic sphingomyelin-
ase and β-glucocerebrosidase, which display a pH opti-
mum below 5  [22] . Since no data are available, investiga-
tions of changes in the lipid composition of the epidermal 
barrier following the application of acidic formulations 
(pH 4) are needed to better understand the underlying 
mechanisms of the constitution and maintenance of a 
physiological and healthy epidermal barrier.
 Disclosure Statement 
 P.B. received honoraria for conducting the above study from 
Dr. August Wolff Arzneimittel GmbH & Co. KG. The authors C.A. 
and M.K. are employees of Dr. August Wolff Arzneimittel GmbH 
& Co. KG. 
 References 
 1 Schreml S, Szeimies RM, Karrer S, Heinlin J, 
Landthaler M, Babilas P: The impact of the 
pH value on skin integrity and cutaneous 
wound healing. J Eur Acad Dermatol Vene-
reol 2010; 24: 373–378. 
 2 Schreml S, Meier, RJ, Weiss KT, Cattani J, 
Flittner D, Gehmert S, Wolfbeis OS, Landthal-
er M, Babilas P: A sprayable luminescent pH 
sensor and its use for wound imaging in vivo. 
Exp Dermatol 2012; 21: 951–953. 
 3 Hachem JP, Behne M, Aronchik I, Demerjian 
M, Feingold KR, Elias PM, Mauro TM: Extra-
cellular pH Controls NHE1 expression in epi-
dermis and keratinocytes: implications for 
barrier repair. J Investig Dermatol 2005; 125: 
 790–797. 
 4 Schmid-Wendtner MH, Korting HC: The pH 
of the skin surface and its impact on the bar-
rier function. Skin Pharmacol Physiol 2006; 
 19: 296–302. 
 5 Yosipovitch G, Maibach HI: Skin surface pH: 
a protective acid mantle. Cosmet Toiletries 
1996; 111: 101–102. 
 6 Schreml S, Kemper M, Abels C: Skin pH in the 
elderly and appropriate skin care. Eur Med J 
Dermatol 2014; 2: 86–94. 
 7 Man MQ, Xin SJ, Song SP, Cho SY, Zhang, XJ, 
Tu CX, Feingold KR, Elias PM: Variation of 
skin surface pH, sebum content and stratum 
corneum hydration with age and gender in a 
large Chinese population. Skin Pharmacol 
Physiol 2009; 22: 190–199. 
 8 Luebberding S, Krueger N, Kerscher M: 
Age-related changes in skin barrier func-
tion  – quantitative evaluation of 150 fe-
male subjects. Int J Cosmet Sci 2013; 35: 183–
190. 
 9 Luebberding S, Krueger N, Kerscher M: Age-
related changes in male skin: quantitative 
evaluation of one hundred and fifty male 
subjects. Skin Pharmacol Physiol 2014; 27: 
 9–17. 
 10 Rippke F, Schreiner V, Schwanitz HJ: The 
acidic milieu of the horny layer. New findings 
on the physiology and pathophysiology of 
skin pH. Am J Clin Dermatol 2002; 3: 261–272. 
 11 Maibach H, Levin J: pH buffering consider-
ations in mature skin. Cosmet Toiletries 2011; 
 126: 422–428. 
 12 Yosipovitch G, Tur E, Cohen O, Rusecki Y: 
Skin surface pH in intertriginous areas in 
 NIDDM patients. Possible correlation to can-
didal intertrigo. Diabetes Care 1993; 16: 560–
563. 
 13 Daniels R, Knie U: Galenik der Dermatika – 
Grundlagen, Eigenschaften, Freisetzung. J 
Dtsch Dermatol Ges 2007; 5: 367–383. 
 14 Babilas P, Knie U, Abels C: Cosmetic and der-
matologic use of alpha hydroxy acids. J Dtsch 
Dermatol Ges 2012; 10: 488–491. 
 Glycolic Acid Effects on Skin Surface pH Skin Pharmacol Physiol 2015;28:290–295
DOI: 10.1159/000439030
295
 15 Schreml S, Meier RJ, Albert MG, Seidl U, 
Zeller V, Behm B, Landthaler M, Abels C, 
Babilas P: The impact of 10% alpha-hydroxy 
acid emulsion on skin pH. Skin Pharmacol 
Physiol 2012; 25: 34–38. 
 16 Lademann J, Ilgevicius A, Zurbau O, Liess 
HD, Schanzer S, Weigmann HJ, Antoniou C, 
Pelchrzim RV, Sterry W: Penetration studies 
of topically applied substances: optical deter-
mination of the amount of stratum corneum 
removed by tape stripping. J Biomed Opt 
2006; 11: 054026. 
 17 Weigmann H, Lademann J, Meffert H, Schae-
fer H, Sterry W: Determination of the horny 
layer profile by tape stripping in combination 
with optical spectroscopy in the visible range 
as a prerequisite to quantify percutaneous ab-
sorption. Skin Pharmacol Appl Skin Physiol 
1999; 12: 34–45. 
 18 Schreml S, Meier RJ, Wolfbeis OS, Landthaler 
M, Szeimies RM, Babilas P: 2D luminescence 
imaging of pH in vivo. Proc Natl Acad Sci 
U S A 2011; 108: 2432–2437. 
 19 Behne MJ, Meyer JW, Hanson KM, Barry NP, 
Murata S, Crumrine D, Clegg RW, Gratton E, 
Holleran WM, Elias PM, Mauro TM: NHE1 
regulates the stratum corneum permeability 
barrier homeostasis. Microenvironment acid-
ification assessed with fluorescence lifetime 
imaging. J Biol Chem 2002; 277: 47399–47406. 
 20 Buraczewska I, Lodén M: Treatment of sur-
factant-damaged skin in humans with creams 
of different pH values. Pharmacology 2005; 
 73: 1–7. 
 21 Blaak J, Wohlfart R, Schürer Y: Treatment of 
aged skin with a pH 4 skin care product nor-
malizes increased skin surface pH and im-
proves barrier function: results of a pilot study. 
J Cosmet Dermatol Sci Appl 2011; 1: 50–58. 
 22 Elias PM: Commentary: stratum corneum 
acidification: how and why? Exp Dermatol 
2015; 24: 179–180. 
